openPR Logo
Press release

Colorectal Cancer Drugs Market Growth, Size, Share and Forecast 2019-2025

05-08-2020 09:00 AM CET | Health & Medicine

Press release from: Orion Market Research

Colorectal Cancer Drugs Market Growth, Size, Share and Forecast

The increasing adoption of personalized medicines for cancer treatment is furthermore augmenting the growth of the colorectal cancer drugs market. Detection of cancer is important for the surgeon or the doctor to find the best-suited therapy that can treat the person. For developing of personalized medicine, several genetic tests need to be taken in account as these tests will eventually reveal the various conditions of the patients such as detection of the individual developing a specific type of cancer. The personalized medicine provides an approach to treat the patient based on the age, sex, type of cancer, the reaction towards a drug and other factors. Personalized medicine holds promise for improving healthcare while lowering costs by enabling each patient to receive earlier diagnoses, optimal treatments, and risk assessments, expected to be a positive indicator for colorectal cancer drugs market growth.

A full report of Global Colorectal Cancer Drugs Market is available at: https://www.omrglobal.com/industry-reports/colorectal-cancer-drugs-market

As per the Personalized Medicine Coalition (PMC) 2017 report, around 42% of all compounds and around 73% of oncology compounds in the pipeline have the potential to be included in personalized medicines. The biopharmaceutical companies closely doubled their R&D investment in personalized medicine over the past five years and suppose to increase their investment in the near future. Moreover, estimates of disease susceptibility or disease prognosis can be improved by combining genomic test results with the knowledge about various factors such as age, lifestyle, or tumor size. This is promising for predicting disease susceptibility, disease prognosis, or drug response of an individual patient.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/colorectal-cancer-drugs-market

Increasing colorectal cancer prevalence is driving the global market

Additionally, the increasing prevalence and incidence of colorectal cancers are also fueling the demand for drugs that are intended to treat colorectal cancer. According to the American Cancer Society, colorectal cancer is diagnosed in more than 1.2 million people globally every year, with North America being the most dominant region. Moreover, the World Health Organization (WHO) has stated that the incidence of colorectal cancer is around 93,898 in men and 85,873 in women; whereas, it has caused mortalities to nearly 33,752 men and 30,369 women during 2018. The increasing prevalence of cancers addresses the need for right treatment solutions including drugs; thereby, drives the global colorectal cancer drugs market.

Current Market Trends Covered in the Global Colorectal Cancer Drugs Market Report

o Based on the drug class type, the immunotherapy segment is estimated to hold a dominating market share during the forecast period.
o Based on the geography, North America is estimated to dominate the global colorectal cancer drugs market during the forecast period.
o Asia-Pacific is anticipated to register the fastest growth in the global colorectal cancer drugs industry during the forecast period.

Global Colorectal Cancer Market Segmentation

By Drug Class Type

o Chemotherapy
o Targeted Therapy
o Immunotherapy
o Hormonal Therapy

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/colorectal-cancer-drugs-market

Global Colorectal Cancer Market - Segment by Region

North America

o United States
o Canada

Europe

o Germany
o United Kingdom
o France
o Spain
o Italy
o Rest of Europe

Asia-Pacific

o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World

o Middle East & Africa
o Latin America

Company Profiles

o AbbVie Inc.
o Amgen Inc.
o AstraZeneca PLC
o Bayer AG
o Bristol-Myers Squibb Co.
o Celgene Corp.
o Eli Lilly and Co.
o F. Hoffmann-La Roche Ltd.
o Merck & Co., Inc.,
o Novartis AG
o Pfizer Inc.
o Sanofi SA

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Drugs Market Growth, Size, Share and Forecast 2019-2025 here

News-ID: 2038779 • Views:

More Releases from Orion Market Research

Microfinance Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Microfinance Market Size, Trends, Latest Insights, Analysis and Forecast 2024-20 …
The global microfinance market is anticipated to grow at a considerable CAGR of around 14.8% during the forecast period (2024-2031). The market growth is driven by the rising demand for finance among the low-income and more overlooked sections of society, government support, and the continuous establishment of microfinance institutions across the globe. The World Bank estimated that over 7,000 microfinance institutions are operating across the globe, serving nearly 16 million
Oral and Dental Probiotics Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Oral and Dental Probiotics Market Size, Trends, Latest Insights, Analysis and Fo …
The global oral and dental probiotics market is anticipated to grow at a CAGR of 8.5% during the forecast period (2024-2031). The market growth is driven by the rising awareness about the oral health benefits associated with oral and dental probiotics. The industry growth is also driven by the increasing popularity of combination products, which integrate probiotics with other oral health-enhancing ingredients. Additionally, the rising preference for natural and preventive
Wireless Health Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Wireless Health Market Size, Trends, Latest Insights, Analysis and Forecast 2024 …
The global wireless health market is anticipated to grow at a significant CAGR of approx. 22.3% during the forecast period (2024-2031). The market growth is driven by the increase demand for chronic disease management solutions, fitness tracking, supporting medication adherence, hampering hospital readmissions, symptom tracking, and managing mental & behavioral health. Additionally, the evolution of healthcare IT is also contributing to market growth through the integration of the Internet of
Antiallergic Non-Drug Supplement Market Will Exhibit an Impressive Expansion by 2024-2031 | General Nutrition Center Holdings, LLC (GNC), Emerald Laboratories
Antiallergic Non-Drug Supplement Market Will Exhibit an Impressive Expansion by …
Antiallergic Non-Drug Supplement Market is anticipated to grow at a significant CAGR during the forecast period. An antiallergic non-drug supplement is a medicinal product that includes various types of nutritional supplements, oils, among others. These supplements are categorized into tablets, capsules, and liquid dosage forms. Antiallergic non-drug supplements can alleviate various types of allergic symptoms and enable allergic patients to deal with the allergic symptoms without using any chemical-based formulations

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top